Professor University of California, San Francisco SAN FRANCISCO, California, United States
Learning Objectives:
Upon completion, participant will be able to describe the clinical syndrome of patients with TRAF3 immunodeficiency.
Upon completion, participant will be aware of the functions of TRAF3 in B cells.
Upon completion, participants will be able to discuss how knowledge of monogenic immune diseases can inform on common genetic variants risks for the wider population.
